Interleukin-4 receptor α-based hybrid peptide effectively induces antitumor activity in head and neck squamous cell carcinoma.
about
Targeting interleukin-4 receptor alpha by hybrid Peptide for novel biliary tract cancer therapy.A Novel Peptide for Simultaneously Enhanced Treatment of Head and Neck Cancer and Mitigation of Oral Mucositis.Differential regulation of surface receptor expression, proliferation, and apoptosis in HaCaT cells stimulated with interferon-γ, interleukin-4, tumor necrosis factor-α, or muramyl dipeptide.
P2860
Interleukin-4 receptor α-based hybrid peptide effectively induces antitumor activity in head and neck squamous cell carcinoma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Interleukin-4 receptor α-based ...... neck squamous cell carcinoma.
@en
Interleukin-4 receptor α-based ...... neck squamous cell carcinoma.
@nl
type
label
Interleukin-4 receptor α-based ...... neck squamous cell carcinoma.
@en
Interleukin-4 receptor α-based ...... neck squamous cell carcinoma.
@nl
prefLabel
Interleukin-4 receptor α-based ...... neck squamous cell carcinoma.
@en
Interleukin-4 receptor α-based ...... neck squamous cell carcinoma.
@nl
P2093
P356
P1433
P1476
Interleukin-4 receptor α-based ...... d neck squamous cell carcinoma
@en
P2093
Eiji Warabi
Hiroki Bukawa
Junichi Shoda
Kahori Seto
Kazunori Ishige
Koji Kawakami
Masayuki Kohno
Tomohisa Horibe
Toru Yanagawa
P304
P356
10.3892/OR.2013.2387
P577
2013-04-04T00:00:00Z